- Report
- February 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- July 2024
- 150 Pages
Global
From €3503EUR$3,750USD£2,964GBP
- Report
- March 2024
- 147 Pages
Global
From €2802EUR$2,999USD£2,370GBP
- Report
- April 2023
- 115 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- March 2024
- 132 Pages
Global
From €888EUR$950USD£751GBP
The Mucosal Atomization Device (MAD) is a type of respiratory device used to deliver medication directly to the mucosal lining of the respiratory tract. It is a handheld device that uses a high-velocity jet of air to atomize medication into a fine mist, which is then inhaled by the patient. MADs are used to treat a variety of respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. MADs are also used to deliver vaccines and other medications to the lungs.
MADs are becoming increasingly popular due to their ease of use and effectiveness in delivering medication directly to the lungs. They are also cost-effective and can be used in both hospital and home settings.
Some companies in the MAD market include PARI Pharma, Omron Healthcare, Philips Respironics, and Aerogen. Show Less Read more